Project 462639
Understanding the epidemiology and burden of invasive Candidal infections and antifungal resistance in Canadian hospitals (Can-EPI-R)
Understanding the epidemiology and burden of invasive Candidal infections and antifungal resistance in Canadian hospitals (Can-EPI-R)
Project Information
| Study Type: | Unclear |
| Research Theme: | Clinical |
Institution & Funding
| Principal Investigator(s): | McGeer, Allison J; Kus, Julianne V |
| Co-Investigator(s): | Allen, Vanessa G; Bharat, Amrita K; Cowen, Leah E; Jamal, Alainna J; Kandel, Christopher; Kozak, Robert A; Mazzulli, Tony; Poutanen, Susan M; Waglechner, Nicholas |
| Institution: | Sinai Health System (Toronto) |
| CIHR Institute: | Infection and Immunity |
| Program: | |
| Peer Review Committee: | Public, Community & Population Health 2 |
| Competition Year: | 2022 |
| Term: | 3 yrs 0 mth |
Abstract Summary
As antimicrobial resistance worsens, and hospital care becomes more and more capable of treating complex diseases, fungal infections are emerging worldwide. As they do, antifungal agents (antibiotics used for treating fungal infections) have been increasingly used and resistance to these agents is also emerging. As yet, there are no Canadian data to assess the burden of these infections and the resistance associated with them. This study will assess the burden of these infections, and collect information about them that will support needed efforts to protect patients from these infections in the future.
No special research characteristics identified
This project does not include any of the advanced research characteristics tracked in our database.